Clominorex

Clominorex is a psychostimulant and anorectic drug that was patented and developed by the pharmaceutical company Yamanouchi Pharmaceutical. It is related to other anorectic agents such as fenfluramine and chlorphentermine.

History[edit | edit source]

Clominorex was first synthesized and patented in the 1960s by Yamanouchi Pharmaceutical. It was developed as a potential treatment for obesity due to its anorectic properties. However, it was never marketed and remains a largely obscure compound.

Pharmacology[edit | edit source]

Clominorex is a norepinephrine-dopamine reuptake inhibitor and releasing agent. It is structurally related to other anorectic agents such as fenfluramine and chlorphentermine, which are also norepinephrine-dopamine reuptake inhibitors. However, unlike these drugs, clominorex does not have any serotonin releasing activity.

Legal Status[edit | edit source]

Clominorex is not currently approved for medical use in any country. It is classified as a Schedule I controlled substance in the United States under the Controlled Substances Act, meaning it has a high potential for abuse and no accepted medical use.

References[edit | edit source]

This pharmacology-related article is a stub. You can help WikiMD by expanding it.

‎

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.